Maternal Lopinavir/Ritonavir Is Associated with Fewer Adverse Events in Infants than Nelfinavir or Atazanavir

<div>Frequency of infant adverse events. Bars represent percentages of infants with laboratory adverse events at birth (age 0–7 days) and at 4 weeks (±2 weeks). Hgb, hemoglobin; ANC, absolute neutrophil count; plts, platelet count; AST, aspartate aminotransferase; ALT, alanine aminotransferase.</div>

Infectious Diseases in Obstetrics and Gynecology

fig1

Figure 1

Figure 1: Maternal Lopinavir/Ritonavir Is Associated with Fewer Adverse Events in Infants than Nelfinavir or Atazanavir 